As an adjunct to standard treatment for patients with type 2 diabetes, liraglutide appears at least as protective against cardiovascular events for patients with chronic kidney disease (CKD) as for those without CKD, according to a subgroup analysis of the LEADER trial published in Circulation.

Synthetic mammogram paired with digital breast tomosynthesis (DBT) achieved similar sensitivity and specificity as full-field digital mammography (FFDM) in identifying microcalcifications during breast screening, according to an Oct. 2 study in Radiology.

Just 39 percent of healthcare organizations and providers are confident in their medical device security, according to report by KLAS, College of Healthcare Information Management Executives (CHIMES) and the Association for Executives in Healthcare Information Security (AEHIS).

Women who experience menopause before age 40 are twice as likely to develop type 2 diabetes (T2D) than those who reach menopause at a more normal age, according to research presented at the European Association for the Study of Diabetes’ annual conference in Berlin last week.

Johns Hopkins University’s Malone Center for Engineering in Healthcare has developed a new algorithm that aims to reduce the number of costly no-show appointments.

Researchers from the Medical University of South Carolina (MUSC) Hollings Cancer Center in Charleston have received a three-year, $1.2 million grant from the U.S. Department of Defense to use molecular imaging tools to test antibody therapies for breast cancer—potentially producing fewer side effects.

A group of young cardiologists in New York City is opening hybrid health clinics, which combine the in-person guidance of physicians with the latest in digital health technology and screening tools.

The average U.S. cardiologist’s salary dropped by 4 percent last year, to $559,568, MedAxiom reported in its annual Cardiovascular Provider Compensation & Production Survey. The dip follows three consecutive years of salary hikes that reached an all-time high in 2016.

NorthStar Medical Radioisotopes in Beloit, Wis. and the Janesville, Wis.-planned SHINE Medical Technologies may receive a portion of the $20 million in federal technology funding bill approved by President Donald Trump to produce molybdenum-99 (Mo-99).